Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

University of Calgary at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

University of Calgary brings 8 presentations to ASH 2026 in New Orleans. Its program spans myeloma, leukemia and inherited blood disorders. Research covers aberrant BCMA splicing as a route to resistance, CRISPR therapy eligibility in sickle cell disease and bleeding disorders of unknown cause.

OrganizationASH 2026 Attendance
University of Calgary
Calgary, Canada
Universities & research institutes
Public research university in Calgary, Alberta, with a medical school.
Symposium
Fri Dec 11
7:00am–10:00am
Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation
Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention.
Myeloma · New drugs

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Calgary

Tell us what you sell and we’ll find the people at University of Calgary most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction